Table 1 The characteristics of the DCIS, IDC-no-relapse and IDC-with-relapse patients included in the study
Patient characteristics | DCIS | IDC - No Relapse | IDC - With Relapse | ||||
|---|---|---|---|---|---|---|---|
n = 30 | (%) | n = 23 | (%) | n = 35 | (%) | ||
Menopause status | Pre-menopause | 3 | (10.0%) | 0 | (0.0%) | 7 | (20.0%) |
Menopause | 7 | (23.3%) | 0 | (0.0%) | 0 | (0.0%) | |
Post-menopause | 8 | (26.7%) | 0 | (0.0%) | 25 | (71.4%) | |
Unknown | 12 | (40.0%) | 23 | (100.0%) | 3 | (8.6%) | |
Node status | N0 | 30 | (100.0%) | 14 | (60.9%) | 17 | (48.6%) |
N1 | 0 | (0.0%) | 4 | (17.4%) | 14 | (40.0%) | |
N2 | 0 | (0.0%) | 1 | (4.4%) | 0 | (0.0%) | |
Unknown | 0 | (0.0%) | 4 | (17.4%) | 4 | (11.4%) | |
Tumor | T0 | 26 | (86.7%) | 0 | (0.0%) | 1 | (2.9%) |
T1 | 0 | (0.0%) | 2 | (8.7%) | 14 | (40.0%) | |
T≥2 | 0 | (0.0%) | 19 | (82.6%) | 17 | (48.6%) | |
Unknown | 4 | (13.3%) | 2 | (8.7%) | 3 | (8.5%) | |
Grade | 1 | 5 | (16.7%) | 6 | (26.1%) | 5 | (14.3%) |
2 | 12 | (40.0%) | 9 | (39.1%) | 10 | (28.6%) | |
3 | 6 | (20.0%) | 5 | (21.7%) | 7 | (20.0%) | |
Unknown | 7 | (23.3%) | 3 | (13.1%) | 13 | (37.1%) | |
Radiotherapy | Yes | 19 | (63.4%) | 17 | (73.9%) | 28 | (80.0%) |
No | 10 | (33.3%) | 5 | (21.7%) | 5 | (14.3%) | |
Unknown | 1 | (3.3%) | 1 | (4.4%) | 2 | (5.7%) | |
Chemotherapy | Yes | 0 | (0.0%) | 17 | (73.9%) | 15 | (42.9%) |
No | 18 | (60.0%) | 5 | (21.7%) | 17 | (48.6%) | |
Unknown | 12 | (40.0%) | 1 | (4.3%) | 3 | (8.5%) | |
Her2-neu | Yes | 3 | (10.0%) | 1 | (4.3%) | 6 | (17.1%) |
No | 1 | (3.3%) | 15 | (65.3%) | 26 | (74.3%) | |
Unknown | 26 | (86.7%) | 7 | (30.4%) | 3 | (8.6%) | |
ER | Yes | 23 | (76.7%) | 20 | (87.0%) | 23 | (65.7%) |
No | 2 | (6.7%) | 2 | (8.7%) | 10 | (28.6%) | |
Unknown | 5 | (16.6%) | 1 | (4.3%) | 2 | (5.7%) | |
PR | Yes | 17 | (56.7%) | 19 | (82.6%) | 19 | (54.3%) |
No | 7 | (23.3%) | 3 | (3.0%) | 13 | (37.1%) | |
Unknown | 6 | (20.0%) | 1 | (4.4%) | 3 | (8.6%) | |